|
26
|
Fidelity Investments
Boston,
Massachusetts
|
$13.7M
|
-$68.7M
|
-3,237,281
|
-83%
|
|
|
27
|
Barclays
London,
United Kingdom
|
$13.4M
|
-$2.5M
|
-117,777
|
-15%
|
|
|
28
|
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$13.2M
|
+$5M
|
+235,409
|
+56%
|
|
|
29
|
Charles Schwab
San Francisco,
California
|
$13.1M
|
-$1.21M
|
-56,908
|
-8%
|
|
|
30
|
Gagnon Securities
New York
|
$12.5M
|
+$6.93M
|
+326,323
|
+109%
|
|
|
31
|
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$12.3M
|
+$4.23M
|
+199,441
|
+48%
|
|
|
32
|
Legion Partners Asset Management
Los Angeles,
California
|
$11.9M
|
–
|
–
|
–
|
|
|
33
|
Two Sigma Investments
New York
|
$10.8M
|
+$5.77M
|
+272,014
|
+102%
|
|
|
34
|
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
$10.3M
|
+$1.02M
|
+48,199
|
+10%
|
|
|
35
|
Tudor Investment Corp
Stamford,
Connecticut
|
$9.87M
|
+$10.4M
|
+492,210
|
New
|
|
|
36
|
Bank of New York Mellon
New York
|
$9.3M
|
+$1.03M
|
+48,692
|
+12%
|
|
|
37
|
Bridgewater Associates
Westport,
Connecticut
|
$9.18M
|
+$3.75M
|
+176,628
|
+63%
|
|
|
38
|
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$9.04M
|
-$4.82M
|
-227,004
|
-33%
|
|
|
39
|
Nuveen
Charlotte,
North Carolina
|
$8.9M
|
-$7.78M
|
-366,567
|
-45%
|
|
|
40
|
AQR Capital Management
Greenwich,
Connecticut
|
$8.68M
|
+$6.84M
|
+322,132
|
+289%
|
|
|
41
|
S Squared Technology
New York
|
$8.63M
|
+$1.7M
|
+80,195
|
+23%
|
|
|
42
|
Glenmede Trust
Philadelphia,
Pennsylvania
|
$8.54M
|
+$9.04M
|
+425,698
|
New
|
|
|
43
|
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$8.03M
|
-$4.18M
|
-196,727
|
-33%
|
|
|
44
|
First Eagle Investment Management
New York
|
$7.28M
|
+$1.43M
|
+67,500
|
+23%
|
|
|
45
|
Herald Investment Management
London,
United Kingdom
|
$7.25M
|
+$1.7M
|
+80,000
|
+28%
|
|
|
46
|
|
$6.74M
|
+$3.58M
|
+168,891
|
+101%
|
|
|
47
|
Balyasny Asset Management
Chicago,
Illinois
|
$5.99M
|
-$7.52M
|
-354,300
|
-54%
|
|
|
48
|
Algert Global
San Francisco,
California
|
$5.59M
|
+$5.92M
|
+278,700
|
New
|
|
|
49
|
Millennium Management
New York
|
$5.38M
|
+$3.14M
|
+147,713
|
+122%
|
|
|
50
|
Invenomic Capital Management
Boston,
Massachusetts
|
$5.34M
|
+$5.65M
|
+266,252
|
New
|
|
